Shunsuke (Sean) Matsuoka is one of the Co-Founders of General Prognostics (GPx) that is revolutionizing remote chronic disease management with the world’s first bloodless blood tests.
Most recently, Sean served as the GM/SVP of Business Development at {caresyntax and M3, where he spearheaded its business development initiatives and brought in investments and commercial contracts from MNC’s/major hospitals. He started his career as a marketer at Sony before pursuing his MBA and worked at McKinsey & Company advising healthcare clients after his MBA. Sean earned a Bachelor’s degree in Law from Keio University and an MBA from Harvard Business School.
